⌘K

Login Start Free

Home/Filings/4/0001077183-20-000227

4//SEC Filing

Weiss Lawrence Martin 4

Accession 0001077183-20-000227

CIK 0001077183other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:51 PM ET

Size

26.5 KB

Accession

0001077183-20-000227

Insider Transaction Report

Form 4

Period: 2020-12-14

NEOGENOMICS INCNEO

Weiss Lawrence Martin

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2020-12-14$19.60/sh+9,005$176,498→ 120,721 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−16,666→ 8,334 total
Exercise: $13.87Exp: 2023-12-12→ Common Stock (16,666 underlying)
Exercise/Conversion
Common Stock
2020-12-14$6.98/sh+50,000$349,000→ 61,717 total
Exercise/Conversion
Common Stock
2020-12-14$7.27/sh+20,000$145,400→ 81,717 total
Exercise/Conversion
Common Stock
2020-12-14$9.22/sh+13,333$122,930→ 95,050 total
Exercise/Conversion
Common Stock
2020-12-14$13.87/sh+16,666$231,157→ 111,716 total
Sale
Common Stock
2020-12-14$51.06/sh−20,200$1,031,412→ 100,521 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−50,000→ 0 total
Exercise: $6.98Exp: 2021-03-01→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−9,005→ 27,017 total
Exercise: $19.60Exp: 2024-03-01→ Common Stock (9,005 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−20,000→ 0 total
Exercise: $7.27Exp: 2022-05-25→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−13,333→ 6,667 total
Exercise: $9.22Exp: 2023-04-19→ Common Stock (13,333 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying)
37,514

Footnotes (6)

[F1]On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F2]On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F3]On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F4]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F5]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F6]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

2 files

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1

filerCIK 0001761625

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 8:51 PM ET
Size: 26.5 KB

View on SEC.gov